| RS2539896387 |
TMEM216
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2539896401 |
TMEM216
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2539896547 |
TMEM216
|
Health Risk |
Likely pathogenic |
Joubert syndrome 2, Joubert syndrome 2 |
| RS2539896601 |
TMEM216
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2539896690 |
TMEM216
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2539897956 |
HKDC1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 92, Retinitis pigmentosa 92 |
| RS2539900762 |
PCDH15
|
Health Risk |
Pathogenic |
Usher syndrome type 1F, Usher syndrome type 1F |
| RS2539901907 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2539902540 |
PCDH15
|
Health Risk |
Likely pathogenic |
— |
| RS2539906008 |
ZMYND11
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2539906042 |
ZMYND11
|
Health Risk |
Pathogenic |
— |
| RS2539909801 |
LRRC56
|
Health Risk |
Likely pathogenic |
— |
| RS2539918923 |
HKDC1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 92, Retinitis pigmentosa 92 |
| RS2539919317 |
KIRREL3
|
Health Risk |
Likely pathogenic |
— |
| RS2539921362 |
LRRC56
|
Health Risk |
Pathogenic |
— |
| RS2539928316 |
LRRC56
|
Health Risk |
Likely pathogenic |
— |
| RS2539929475 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2539931430 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2539931796 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2539932445 |
LRRC56
|
Health Risk |
Pathogenic |
— |
| RS2539933089 |
LRRC56
|
Health Risk |
Pathogenic |
— |
| RS2539939984 |
ITGA7
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, Congenital muscular dystrophy due to integrin alpha-7 deficiency |
| RS2539945228 |
PTPRO
|
Health Risk |
Pathogenic |
— |
| RS2539962892 |
PTHLH
|
Health Risk |
Pathogenic |
— |
| RS2539963351 |
VDR
|
Health Risk |
Pathogenic |
— |
| RS2539965571 |
VDR
|
Health Risk |
Pathogenic |
— |
| RS2539969091 |
VDR
|
Health Risk |
Likely pathogenic |
— |
| RS2539969247 |
VDR
|
Health Risk |
Pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS2539971705 |
PTHLH
|
Health Risk |
Likely pathogenic |
— |
| RS2539971709 |
PTHLH
|
Health Risk |
Likely pathogenic |
— |
| RS2539985015 |
VDR
|
Health Risk |
Pathogenic |
— |
| RS2539985441 |
FKTN
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS2539990210 |
PTPRO
|
Health Risk |
Pathogenic |
— |
| RS2539996264 |
VDR
|
Health Risk |
Pathogenic |
— |
| RS2540002344 |
RDH5
|
Health Risk |
Pathogenic |
— |
| RS2540004166 |
RDH5
|
Health Risk |
Pathogenic |
— |
| RS2540004249 |
RDH5
|
Health Risk |
Likely pathogenic |
— |
| RS2540007941 |
ZMYND11
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2540008595 |
ZMYND11
|
Health Risk |
Pathogenic |
— |
| RS2540008767 |
ZMYND11
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2540009501 |
ZMYND11
|
Health Risk |
Likely pathogenic |
ZMYND11-related disorder, ZMYND11-related disorder |
| RS2540011572 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2540011642 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2540012395 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1F |
| RS2540017090 |
VDR
|
Health Risk |
Likely pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS2540017785 |
VDR
|
Health Risk |
Likely pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS2540023102 |
ZMYND11
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2540040198 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2540040738 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2540043491 |
ZMYND11
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2540044081 |
ZMYND11
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2540044767 |
TMEM38B
|
Health Risk |
Pathogenic |
— |
| RS2540045622 |
TMEM38B
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 14, Osteogenesis imperfecta type 14 |
| RS2540045854 |
ZMYND11
|
Health Risk |
Pathogenic |
— |
| RS2540045968 |
FGFR2
|
Health Risk |
Pathogenic |
FGFR2-related craniosynostosis, FGFR2-related craniosynostosis |
| RS2540046247 |
ZMYND11
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2540049055 |
FGFR2
|
Health Risk |
Conflicting classifications of pathogenicity |
FGFR2-related craniosynostosis, Crouzon syndrome |
| RS2540049261 |
FGFR2
|
Health Risk |
Pathogenic |
FGFR2-related craniosynostosis, FGFR2-related craniosynostosis |
| RS2540056456 |
ZMYND11
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2540059310 |
ZMYND11
|
Health Risk |
Likely pathogenic |
— |
| RS2540060643 |
HOGA1
|
Health Risk |
Pathogenic |
— |
| RS2540060652 |
HOGA1
|
Health Risk |
Pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS2540060692 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS2540060695 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS2540072817 |
VAMP1
|
Health Risk |
Likely pathogenic |
Spastic ataxia 1, Spastic ataxia 1 |
| RS2540074052 |
HOGA1
|
Health Risk |
Pathogenic |
— |
| RS2540074585 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS2540074927 |
HOGA1
|
Health Risk |
Likely pathogenic |
— |
| RS2540075778 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS2540078331 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS2540086673 |
HOGA1
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria type 3, Primary hyperoxaluria type 3 |
| RS2540086681 |
HOGA1
|
Health Risk |
Pathogenic |
— |
| RS2540086855 |
HOGA1
|
Health Risk |
Likely pathogenic |
— |
| RS2540091081 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540091565 |
COL2A1
|
Health Risk |
Likely pathogenic |
Achondrogenesis type II, Achondrogenesis type II |
| RS2540091768 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540092140 |
LPL
|
Health Risk |
Likely pathogenic |
— |
| RS2540092267 |
LPL
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540092337 |
LPL
|
Health Risk |
Likely pathogenic |
— |
| RS2540094178 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540094531 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540094630 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540094635 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540094660 |
COL2A1
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2540094982 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540095140 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540095238 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540095473 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540096951 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540097262 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540097285 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2540097499 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540097518 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540097718 |
COL2A1
|
Health Risk |
Pathogenic |
COL2A1-related disorder, COL2A1-related disorder |
| RS2540097776 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540097812 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540099804 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2540099807 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540099833 |
LPL
|
Health Risk |
Pathogenic |
— |
| RS2540100393 |
COL2A1
|
Health Risk |
Pathogenic |
— |